Shopping Cart 0
Cart Subtotal
USD 0

Global Ophthalmic Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 3480

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 5220

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 6960
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Ophthalmic drugs are extensively used to treat glaucoma, cataract, diabetic retinopathy, and other ophthalmic disorders. Introduction of novel ocular drug delivery approaches in the market has driven the manufacturers to develop innovative therapeutic approaches for the treatment of ophthalmic disorders.

Scope of the Report:

This report focuses on the Ophthalmic Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The other key factors that boost the ophthalmic drug market size include high prevalence of glaucoma worldwide and rise in transition towards development of combination therapies for the treatment of glaucoma.

According to the American Academy of Ophthalmology over 27.1 million of North American population is suffering from Primary Open Angle Glaucoma (POAG) and this number is constantly rising. Thus, increasing eye disorders is fueling the growth of the global ophthalmic drugs market.

It was reported that around two-third of the population in the Asia Pacific region are blind or vision impaired. Moreover, development of various novel technologies in developing markets such as China & India is expected to improve healthcare facilities.

The worldwide market for Ophthalmic Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million USD in 2023, from xx million USD in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Santen Pharmaceutical

Valeant Pharmaceuticals

Shire

Novartis

Genentech

Allergan

Sun Pharmaceutical Industries

Actavis Generics

Regeneron Pharmaceuticals

Pfizer

Johnson and Johnson

Bausch and Lomb

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Anti-allergy

Anti-VEGF Agents

Anti-inflammatory

Anti-glaucoma

Market Segment by Applications, can be divided into

Hospital

Clinic

Pharmacy

There are 15 Chapters to deeply display the global Ophthalmic Drugs market.

Chapter 1, to describe Ophthalmic Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Ophthalmic Drugs, with sales, revenue, and price of Ophthalmic Drugs, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Ophthalmic Drugs, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Ophthalmic Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Ophthalmic Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

READ MORE

Table Of Content

Scope

Table of Contents

1 Market Overview

1.1 Ophthalmic Drugs Introduction

1.2 Market Analysis by Type

1.2.1 Anti-allergy

1.2.2 Anti-VEGF Agents

1.2.3 Anti-inflammatory

1.2.4 Anti-glaucoma

1.3 Market Analysis by Applications

1.3.1 Hospital

1.3.2 Clinic

1.3.3 Pharmacy

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Santen Pharmaceutical

2.1.1 Business Overview

2.1.2 Ophthalmic Drugs Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Santen Pharmaceutical Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Valeant Pharmaceuticals

2.2.1 Business Overview

2.2.2 Ophthalmic Drugs Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Valeant Pharmaceuticals Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Shire

2.3.1 Business Overview

2.3.2 Ophthalmic Drugs Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Shire Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Novartis

2.4.1 Business Overview

2.4.2 Ophthalmic Drugs Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Novartis Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Genentech

2.5.1 Business Overview

2.5.2 Ophthalmic Drugs Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Genentech Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Allergan

2.6.1 Business Overview

2.6.2 Ophthalmic Drugs Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Allergan Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Sun Pharmaceutical Industries

2.7.1 Business Overview

2.7.2 Ophthalmic Drugs Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Sun Pharmaceutical Industries Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Actavis Generics

2.8.1 Business Overview

2.8.2 Ophthalmic Drugs Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Actavis Generics Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Regeneron Pharmaceuticals

2.9.1 Business Overview

2.9.2 Ophthalmic Drugs Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Regeneron Pharmaceuticals Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 Pfizer

2.10.1 Business Overview

2.10.2 Ophthalmic Drugs Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Pfizer Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.11 Johnson and Johnson

2.11.1 Business Overview

2.11.2 Ophthalmic Drugs Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Johnson and Johnson Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.12 Bausch and Lomb

2.12.1 Business Overview

2.12.2 Ophthalmic Drugs Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Bausch and Lomb Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Ophthalmic Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Ophthalmic Drugs Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Ophthalmic Drugs Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Ophthalmic Drugs Manufacturer Market Share in 2017

3.3.2 Top 6 Ophthalmic Drugs Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Ophthalmic Drugs Market Analysis by Regions

4.1 Global Ophthalmic Drugs Sales, Revenue and Market Share by Regions

4.1.1 Global Ophthalmic Drugs Sales and Market Share by Regions (2013-2018)

4.1.2 Global Ophthalmic Drugs Revenue and Market Share by Regions (2013-2018)

4.2 North America Ophthalmic Drugs Sales and Growth Rate (2013-2018)

4.3 Europe Ophthalmic Drugs Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Ophthalmic Drugs Sales and Growth Rate (2013-2018)

4.5 South America Ophthalmic Drugs Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Ophthalmic Drugs Sales and Growth Rate (2013-2018)

5 North America Ophthalmic Drugs by Countries

5.1 North America Ophthalmic Drugs Sales, Revenue and Market Share by Countries

5.1.1 North America Ophthalmic Drugs Sales and Market Share by Countries (2013-2018)

5.1.2 North America Ophthalmic Drugs Revenue and Market Share by Countries (2013-2018)

5.2 United States Ophthalmic Drugs Sales and Growth Rate (2013-2018)

5.3 Canada Ophthalmic Drugs Sales and Growth Rate (2013-2018)

5.4 Mexico Ophthalmic Drugs Sales and Growth Rate (2013-2018)

6 Europe Ophthalmic Drugs by Countries

6.1 Europe Ophthalmic Drugs Sales, Revenue and Market Share by Countries

6.1.1 Europe Ophthalmic Drugs Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Ophthalmic Drugs Revenue and Market Share by Countries (2013-2018)

6.2 Germany Ophthalmic Drugs Sales and Growth Rate (2013-2018)

6.3 UK Ophthalmic Drugs Sales and Growth Rate (2013-2018)

6.4 France Ophthalmic Drugs Sales and Growth Rate (2013-2018)

6.5 Russia Ophthalmic Drugs Sales and Growth Rate (2013-2018)

6.6 Italy Ophthalmic Drugs Sales and Growth Rate (2013-2018)

7 Asia-Pacific Ophthalmic Drugs by Countries

7.1 Asia-Pacific Ophthalmic Drugs Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Ophthalmic Drugs Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Ophthalmic Drugs Revenue and Market Share by Countries (2013-2018)

7.2 China Ophthalmic Drugs Sales and Growth Rate (2013-2018)

7.3 Japan Ophthalmic Drugs Sales and Growth Rate (2013-2018)

7.4 Korea Ophthalmic Drugs Sales and Growth Rate (2013-2018)

7.5 India Ophthalmic Drugs Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Ophthalmic Drugs Sales and Growth Rate (2013-2018)

8 South America Ophthalmic Drugs by Countries

8.1 South America Ophthalmic Drugs Sales, Revenue and Market Share by Countries

8.1.1 South America Ophthalmic Drugs Sales and Market Share by Countries (2013-2018)

8.1.2 South America Ophthalmic Drugs Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Ophthalmic Drugs Sales and Growth Rate (2013-2018)

8.3 Argentina Ophthalmic Drugs Sales and Growth Rate (2013-2018)

8.4 Colombia Ophthalmic Drugs Sales and Growth Rate (2013-2018)

9 Middle East and Africa Ophthalmic Drugs by Countries

9.1 Middle East and Africa Ophthalmic Drugs Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Ophthalmic Drugs Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Ophthalmic Drugs Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Ophthalmic Drugs Sales and Growth Rate (2013-2018)

9.3 UAE Ophthalmic Drugs Sales and Growth Rate (2013-2018)

9.4 Egypt Ophthalmic Drugs Sales and Growth Rate (2013-2018)

9.5 Nigeria Ophthalmic Drugs Sales and Growth Rate (2013-2018)

9.6 South Africa Ophthalmic Drugs Sales and Growth Rate (2013-2018)

10 Global Ophthalmic Drugs Market Segment by Type

10.1 Global Ophthalmic Drugs Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Ophthalmic Drugs Sales and Market Share by Type (2013-2018)

10.1.2 Global Ophthalmic Drugs Revenue and Market Share by Type (2013-2018)

10.2 Anti-allergy Sales Growth and Price

10.2.1 Global Anti-allergy Sales Growth (2013-2018)

10.2.2 Global Anti-allergy Price (2013-2018)

10.3 Anti-VEGF Agents Sales Growth and Price

10.3.1 Global Anti-VEGF Agents Sales Growth (2013-2018)

10.3.2 Global Anti-VEGF Agents Price (2013-2018)

10.4 Anti-inflammatory Sales Growth and Price

10.4.1 Global Anti-inflammatory Sales Growth (2013-2018)

10.4.2 Global Anti-inflammatory Price (2013-2018)

10.5 Anti-glaucoma Sales Growth and Price

10.5.1 Global Anti-glaucoma Sales Growth (2013-2018)

10.5.2 Global Anti-glaucoma Price (2013-2018)

11 Global Ophthalmic Drugs Market Segment by Application

11.1 Global Ophthalmic Drugs Sales Market Share by Application (2013-2018)

11.2 Hospital Sales Growth (2013-2018)

11.3 Clinic Sales Growth (2013-2018)

11.4 Pharmacy Sales Growth (2013-2018)

12 Ophthalmic Drugs Market Forecast (2018-2023)

12.1 Global Ophthalmic Drugs Sales, Revenue and Growth Rate (2018-2023)

12.2 Ophthalmic Drugs Market Forecast by Regions (2018-2023)

12.2.1 North America Ophthalmic Drugs Market Forecast (2018-2023)

12.2.2 Europe Ophthalmic Drugs Market Forecast (2018-2023)

12.2.3 Asia-Pacific Ophthalmic Drugs Market Forecast (2018-2023)

12.2.4 South America Ophthalmic Drugs Market Forecast (2018-2023)

12.2.5 Middle East and Africa Ophthalmic Drugs Market Forecast (2018-2023)

12.3 Ophthalmic Drugs Market Forecast by Type (2018-2023)

12.3.1 Global Ophthalmic Drugs Sales Forecast by Type (2018-2023)

12.3.2 Global Ophthalmic Drugs Market Share Forecast by Type (2018-2023)

12.4 Ophthalmic Drugs Market Forecast by Application (2018-2023)

12.4.1 Global Ophthalmic Drugs Sales Forecast by Application (2018-2023)

12.4.2 Global Ophthalmic Drugs Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source


List Of Table

List of Tables and Figures

Figure Ophthalmic Drugs Picture

Table Product Specifications of Ophthalmic Drugs

Figure Global Sales Market Share of Ophthalmic Drugs by Types in 2017

Table Ophthalmic Drugs Types for Major Manufacturers

Figure Anti-allergy Picture

Figure Anti-VEGF Agents Picture

Figure Anti-inflammatory Picture

Figure Anti-glaucoma Picture

Figure Ophthalmic Drugs Sales Market Share by Applications in 2017

Figure Hospital Picture

Figure Clinic Picture

Figure Pharmacy Picture

Figure United States Ophthalmic Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Canada Ophthalmic Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Mexico Ophthalmic Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Germany Ophthalmic Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure France Ophthalmic Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure UK Ophthalmic Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Russia Ophthalmic Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Italy Ophthalmic Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure China Ophthalmic Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Japan Ophthalmic Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Korea Ophthalmic Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure India Ophthalmic Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Southeast Asia Ophthalmic Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Brazil Ophthalmic Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Egypt Ophthalmic Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Saudi Arabia Ophthalmic Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure South Africa Ophthalmic Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Nigeria Ophthalmic Drugs Revenue (Value) and Growth Rate (2013-2023)

Table Santen Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table Santen Pharmaceutical Ophthalmic Drugs Type and Applications

Table Santen Pharmaceutical Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Valeant Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Valeant Pharmaceuticals Ophthalmic Drugs Type and Applications

Table Valeant Pharmaceuticals Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Shire Basic Information, Manufacturing Base and Competitors

Table Shire Ophthalmic Drugs Type and Applications

Table Shire Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Novartis Basic Information, Manufacturing Base and Competitors

Table Novartis Ophthalmic Drugs Type and Applications

Table Novartis Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Genentech Basic Information, Manufacturing Base and Competitors

Table Genentech Ophthalmic Drugs Type and Applications

Table Genentech Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Allergan Basic Information, Manufacturing Base and Competitors

Table Allergan Ophthalmic Drugs Type and Applications

Table Allergan Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors

Table Sun Pharmaceutical Industries Ophthalmic Drugs Type and Applications

Table Sun Pharmaceutical Industries Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Actavis Generics Basic Information, Manufacturing Base and Competitors

Table Actavis Generics Ophthalmic Drugs Type and Applications

Table Actavis Generics Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Regeneron Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Regeneron Pharmaceuticals Ophthalmic Drugs Type and Applications

Table Regeneron Pharmaceuticals Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Pfizer Basic Information, Manufacturing Base and Competitors

Table Pfizer Ophthalmic Drugs Type and Applications

Table Pfizer Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Johnson and Johnson Basic Information, Manufacturing Base and Competitors

Table Johnson and Johnson Ophthalmic Drugs Type and Applications

Table Johnson and Johnson Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Bausch and Lomb Basic Information, Manufacturing Base and Competitors

Table Bausch and Lomb Ophthalmic Drugs Type and Applications

Table Bausch and Lomb Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Global Ophthalmic Drugs Sales by Manufacturer (2016-2017)

Figure Global Ophthalmic Drugs Sales Market Share by Manufacturer in 2016

Figure Global Ophthalmic Drugs Sales Market Share by Manufacturer in 2017

Table Global Ophthalmic Drugs Revenue by Manufacturer (2016-2017)

Figure Global Ophthalmic Drugs Revenue Market Share by Manufacturer in 2016

Figure Global Ophthalmic Drugs Revenue Market Share by Manufacturer in 2017

Figure Top 3 Ophthalmic Drugs Manufacturer (Revenue) Market Share in 2017

Figure Top 6 Ophthalmic Drugs Manufacturer (Revenue) Market Share in 2017

Figure Global Ophthalmic Drugs Sales and Growth Rate (2013-2018)

Figure Global Ophthalmic Drugs Revenue and Growth Rate (2013-2018)

Table Global Ophthalmic Drugs Sales by Regions (2013-2018)

Table Global Ophthalmic Drugs Sales Market Share by Regions (2013-2018)

Table Global Ophthalmic Drugs Revenue by Regions (2013-2018)

Figure Global Ophthalmic Drugs Revenue Market Share by Regions in 2013

Figure Global Ophthalmic Drugs Revenue Market Share by Regions in 2017

Figure North America Ophthalmic Drugs Sales and Growth Rate (2013-2018)

Figure Europe Ophthalmic Drugs Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Ophthalmic Drugs Sales and Growth Rate (2013-2018)

Figure South America Ophthalmic Drugs Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Ophthalmic Drugs Sales and Growth Rate (2013-2018)

Figure North America Ophthalmic Drugs Revenue and Growth Rate (2013-2018)

Table North America Ophthalmic Drugs Sales by Countries (2013-2018)

Table North America Ophthalmic Drugs Sales Market Share by Countries (2013-2018)

Figure North America Ophthalmic Drugs Sales Market Share by Countries in 2013

Figure North America Ophthalmic Drugs Sales Market Share by Countries in 2017

Table North America Ophthalmic Drugs Revenue by Countries (2013-2018)

Table North America Ophthalmic Drugs Revenue Market Share by Countries (2013-2018)

Figure North America Ophthalmic Drugs Revenue Market Share by Countries in 2013

Figure North America Ophthalmic Drugs Revenue Market Share by Countries in 2017

Figure United States Ophthalmic Drugs Sales and Growth Rate (2013-2018)

Figure Canada Ophthalmic Drugs Sales and Growth Rate (2013-2018)

Figure Mexico Ophthalmic Drugs Sales and Growth Rate (2013-2018)

Figure Europe Ophthalmic Drugs Revenue and Growth Rate (2013-2018)

Table Europe Ophthalmic Drugs Sales by Countries (2013-2018)

Table Europe Ophthalmic Drugs Sales Market Share by Countries (2013-2018)

Table Europe Ophthalmic Drugs Revenue by Countries (2013-2018)

Figure Europe Ophthalmic Drugs Revenue Market Share by Countries in 2016

Figure Europe Ophthalmic Drugs Revenue Market Share by Countries in 2017

Figure Germany Ophthalmic Drugs Sales and Growth Rate (2013-2018)

Figure UK Ophthalmic Drugs Sales and Growth Rate (2013-2018)

Figure France Ophthalmic Drugs Sales and Growth Rate (2013-2018)

Figure Russia Ophthalmic Drugs Sales and Growth Rate (2013-2018)

Figure Italy Ophthalmic Drugs Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Ophthalmic Drugs Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Ophthalmic Drugs Sales by Countries (2013-2018)

Table Asia-Pacific Ophthalmic Drugs Sales Market Share by Countries (2013-2018)

Figure Asia-Pacific Ophthalmic Drugs Sales Market Share by Countries 2017

Table Asia-Pacific Ophthalmic Drugs Revenue by Countries (2013-2018)

Figure Asia-Pacific Ophthalmic Drugs Revenue Market Share by Countries 2017

Figure China Ophthalmic Drugs Sales and Growth Rate (2013-2018)

Figure Japan Ophthalmic Drugs Sales and Growth Rate (2013-2018)

Figure Korea Ophthalmic Drugs Sales and Growth Rate (2013-2018)

Figure India Ophthalmic Drugs Sales and Growth Rate (2013-2018)

Figure Southeast Asia Ophthalmic Drugs Sales and Growth Rate (2013-2018)

Figure South America Ophthalmic Drugs Revenue and Growth Rate (2013-2018)

Table South America Ophthalmic Drugs Sales by Countries (2013-2018)

Table South America Ophthalmic Drugs Sales Market Share by Countries (2013-2018)

Figure South America Ophthalmic Drugs Sales Market Share by Countries in 2017

Table South America Ophthalmic Drugs Revenue by Countries (2013-2018)

Table South America Ophthalmic Drugs Revenue Market Share by Countries (2013-2018)

Figure South America Ophthalmic Drugs Revenue Market Share by Countries in 2017

Figure Brazil Ophthalmic Drugs Sales and Growth Rate (2013-2018)

Figure Argentina Ophthalmic Drugs Sales and Growth Rate (2013-2018)

Figure Colombia Ophthalmic Drugs Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Ophthalmic Drugs Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Ophthalmic Drugs Sales by Countries (2013-2018)

Table Middle East and Africa Ophthalmic Drugs Sales Market Share by Countries (2013-2018)

Figure Middle East and Africa Ophthalmic Drugs Sales Market Share by Countries in 2017

Table Middle East and Africa Ophthalmic Drugs Revenue by Countries (2013-2018)

Table Middle East and Africa Ophthalmic Drugs Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Ophthalmic Drugs Revenue Market Share by Countries in 2013

Figure Middle East and Africa Ophthalmic Drugs Revenue Market Share by Countries in 2017

Figure Saudi Arabia Ophthalmic Drugs Sales and Growth Rate (2013-2018)

Figure UAE Ophthalmic Drugs Sales and Growth Rate (2013-2018)

Figure Egypt Ophthalmic Drugs Sales and Growth Rate (2013-2018)

Figure Nigeria Ophthalmic Drugs Sales and Growth Rate (2013-2018)

Figure South Africa Ophthalmic Drugs Sales and Growth Rate (2013-2018)

Table Global Ophthalmic Drugs Sales by Type (2013-2018)

Table Global Ophthalmic Drugs Sales Share by Type (2013-2018)

Table Global Ophthalmic Drugs Revenue by Type (2013-2018)

Table Global Ophthalmic Drugs Revenue Share by Type (2013-2018)

Figure Global Anti-allergy Sales Growth (2013-2018)

Figure Global Anti-allergy Price (2013-2018)

Figure Global Anti-VEGF Agents Sales Growth (2013-2018)

Figure Global Anti-VEGF Agents Price (2013-2018)

Figure Global Anti-inflammatory Sales Growth (2013-2018)

Figure Global Anti-inflammatory Price (2013-2018)

Figure Global Anti-glaucoma Sales Growth (2013-2018)

Figure Global Anti-glaucoma Price (2013-2018)

Table Global Ophthalmic Drugs Sales by Application (2013-2018)

Table Global Ophthalmic Drugs Sales Share by Application (2013-2018)

Figure Global Clinic Sales Growth (2013-2018)

Figure Global Pharmacy Sales Growth (2013-2018)

Figure Global Ophthalmic Drugs Sales, Revenue and Growth Rate (2018-2023)

Table Global Ophthalmic Drugs Sales Forecast by Regions (2018-2023)

Table Global Ophthalmic Drugs Market Share Forecast by Regions (2018-2023)

Figure North America Sales Ophthalmic Drugs Market Forecast (2018-2023)

Figure Europe Sales Ophthalmic Drugs Market Forecast (2018-2023)

Figure Asia-Pacific Sales Ophthalmic Drugs Market Forecast (2018-2023)

Figure South America Sales Ophthalmic Drugs Market Forecast (2018-2023)

Figure Middle East and Africa Sales Ophthalmic Drugs Market Forecast (2018-2023)

Table Global Ophthalmic Drugs Sales Forecast by Type (2018-2023)

Table Global Ophthalmic Drugs Market Share Forecast by Type (2018-2023)

Table Global Ophthalmic Drugs Sales Forecast by Application (2018-2023)

Table Global Ophthalmic Drugs Market Share Forecast by Application (2018-2023)

Table Distributors/Traders/ Dealers List

Licence Rights

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

Santen Pharmaceutical

Valeant Pharmaceuticals

Shire

Novartis

Genentech

Allergan

Sun Pharmaceutical Industries

Actavis Generics

Regeneron Pharmaceuticals

Pfizer

Johnson and Johnson

Bausch and Lomb

Ophthalmic drugs are extensively used to treat glaucoma, cataract, diabetic retinopathy, and other ophthalmic disorders. Introduction of novel ocular drug delivery approaches in the market has driven the manufacturers to develop innovative therapeutic approaches for the treatment of ophthalmic disorders.

Scope of the Report:

This report focuses on the Ophthalmic Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The other key factors that boost the ophthalmic drug market size include high prevalence of glaucoma worldwide and rise in transition towards development of combination therapies for the treatment of glaucoma.

According to the American Academy of Ophthalmology over 27.1 million of North American population is suffering from Primary Open Angle Glaucoma (POAG) and this number is constantly rising. Thus, increasing eye disorders is fueling the growth of the global ophthalmic drugs market.

It was reported that around two-third of the population in the Asia Pacific region are blind or vision impaired. Moreover, development of various novel technologies in developing markets such as China & India is expected to improve healthcare facilities.

The worldwide market for Ophthalmic Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million USD in 2023, from xx million USD in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Santen Pharmaceutical

Valeant Pharmaceuticals

Shire

Novartis

Genentech

Allergan

Sun Pharmaceutical Industries

Actavis Generics

Regeneron Pharmaceuticals

Pfizer

Johnson and Johnson

Bausch and Lomb

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Anti-allergy

Anti-VEGF Agents

Anti-inflammatory

Anti-glaucoma

Market Segment by Applications, can be divided into

Hospital

Clinic

Pharmacy

There are 15 Chapters to deeply display the global Ophthalmic Drugs market.

Chapter 1, to describe Ophthalmic Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Ophthalmic Drugs, with sales, revenue, and price of Ophthalmic Drugs, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Ophthalmic Drugs, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Ophthalmic Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Ophthalmic Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

READ MORE

Scope

Table of Contents

1 Market Overview

1.1 Ophthalmic Drugs Introduction

1.2 Market Analysis by Type

1.2.1 Anti-allergy

1.2.2 Anti-VEGF Agents

1.2.3 Anti-inflammatory

1.2.4 Anti-glaucoma

1.3 Market Analysis by Applications

1.3.1 Hospital

1.3.2 Clinic

1.3.3 Pharmacy

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Santen Pharmaceutical

2.1.1 Business Overview

2.1.2 Ophthalmic Drugs Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Santen Pharmaceutical Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Valeant Pharmaceuticals

2.2.1 Business Overview

2.2.2 Ophthalmic Drugs Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Valeant Pharmaceuticals Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Shire

2.3.1 Business Overview

2.3.2 Ophthalmic Drugs Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Shire Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Novartis

2.4.1 Business Overview

2.4.2 Ophthalmic Drugs Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Novartis Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Genentech

2.5.1 Business Overview

2.5.2 Ophthalmic Drugs Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Genentech Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Allergan

2.6.1 Business Overview

2.6.2 Ophthalmic Drugs Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Allergan Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Sun Pharmaceutical Industries

2.7.1 Business Overview

2.7.2 Ophthalmic Drugs Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Sun Pharmaceutical Industries Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Actavis Generics

2.8.1 Business Overview

2.8.2 Ophthalmic Drugs Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Actavis Generics Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Regeneron Pharmaceuticals

2.9.1 Business Overview

2.9.2 Ophthalmic Drugs Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Regeneron Pharmaceuticals Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 Pfizer

2.10.1 Business Overview

2.10.2 Ophthalmic Drugs Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Pfizer Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.11 Johnson and Johnson

2.11.1 Business Overview

2.11.2 Ophthalmic Drugs Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Johnson and Johnson Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.12 Bausch and Lomb

2.12.1 Business Overview

2.12.2 Ophthalmic Drugs Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Bausch and Lomb Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Ophthalmic Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Ophthalmic Drugs Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Ophthalmic Drugs Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Ophthalmic Drugs Manufacturer Market Share in 2017

3.3.2 Top 6 Ophthalmic Drugs Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Ophthalmic Drugs Market Analysis by Regions

4.1 Global Ophthalmic Drugs Sales, Revenue and Market Share by Regions

4.1.1 Global Ophthalmic Drugs Sales and Market Share by Regions (2013-2018)

4.1.2 Global Ophthalmic Drugs Revenue and Market Share by Regions (2013-2018)

4.2 North America Ophthalmic Drugs Sales and Growth Rate (2013-2018)

4.3 Europe Ophthalmic Drugs Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Ophthalmic Drugs Sales and Growth Rate (2013-2018)

4.5 South America Ophthalmic Drugs Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Ophthalmic Drugs Sales and Growth Rate (2013-2018)

5 North America Ophthalmic Drugs by Countries

5.1 North America Ophthalmic Drugs Sales, Revenue and Market Share by Countries

5.1.1 North America Ophthalmic Drugs Sales and Market Share by Countries (2013-2018)

5.1.2 North America Ophthalmic Drugs Revenue and Market Share by Countries (2013-2018)

5.2 United States Ophthalmic Drugs Sales and Growth Rate (2013-2018)

5.3 Canada Ophthalmic Drugs Sales and Growth Rate (2013-2018)

5.4 Mexico Ophthalmic Drugs Sales and Growth Rate (2013-2018)

6 Europe Ophthalmic Drugs by Countries

6.1 Europe Ophthalmic Drugs Sales, Revenue and Market Share by Countries

6.1.1 Europe Ophthalmic Drugs Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Ophthalmic Drugs Revenue and Market Share by Countries (2013-2018)

6.2 Germany Ophthalmic Drugs Sales and Growth Rate (2013-2018)

6.3 UK Ophthalmic Drugs Sales and Growth Rate (2013-2018)

6.4 France Ophthalmic Drugs Sales and Growth Rate (2013-2018)

6.5 Russia Ophthalmic Drugs Sales and Growth Rate (2013-2018)

6.6 Italy Ophthalmic Drugs Sales and Growth Rate (2013-2018)

7 Asia-Pacific Ophthalmic Drugs by Countries

7.1 Asia-Pacific Ophthalmic Drugs Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Ophthalmic Drugs Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Ophthalmic Drugs Revenue and Market Share by Countries (2013-2018)

7.2 China Ophthalmic Drugs Sales and Growth Rate (2013-2018)

7.3 Japan Ophthalmic Drugs Sales and Growth Rate (2013-2018)

7.4 Korea Ophthalmic Drugs Sales and Growth Rate (2013-2018)

7.5 India Ophthalmic Drugs Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Ophthalmic Drugs Sales and Growth Rate (2013-2018)

8 South America Ophthalmic Drugs by Countries

8.1 South America Ophthalmic Drugs Sales, Revenue and Market Share by Countries

8.1.1 South America Ophthalmic Drugs Sales and Market Share by Countries (2013-2018)

8.1.2 South America Ophthalmic Drugs Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Ophthalmic Drugs Sales and Growth Rate (2013-2018)

8.3 Argentina Ophthalmic Drugs Sales and Growth Rate (2013-2018)

8.4 Colombia Ophthalmic Drugs Sales and Growth Rate (2013-2018)

9 Middle East and Africa Ophthalmic Drugs by Countries

9.1 Middle East and Africa Ophthalmic Drugs Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Ophthalmic Drugs Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Ophthalmic Drugs Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Ophthalmic Drugs Sales and Growth Rate (2013-2018)

9.3 UAE Ophthalmic Drugs Sales and Growth Rate (2013-2018)

9.4 Egypt Ophthalmic Drugs Sales and Growth Rate (2013-2018)

9.5 Nigeria Ophthalmic Drugs Sales and Growth Rate (2013-2018)

9.6 South Africa Ophthalmic Drugs Sales and Growth Rate (2013-2018)

10 Global Ophthalmic Drugs Market Segment by Type

10.1 Global Ophthalmic Drugs Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Ophthalmic Drugs Sales and Market Share by Type (2013-2018)

10.1.2 Global Ophthalmic Drugs Revenue and Market Share by Type (2013-2018)

10.2 Anti-allergy Sales Growth and Price

10.2.1 Global Anti-allergy Sales Growth (2013-2018)

10.2.2 Global Anti-allergy Price (2013-2018)

10.3 Anti-VEGF Agents Sales Growth and Price

10.3.1 Global Anti-VEGF Agents Sales Growth (2013-2018)

10.3.2 Global Anti-VEGF Agents Price (2013-2018)

10.4 Anti-inflammatory Sales Growth and Price

10.4.1 Global Anti-inflammatory Sales Growth (2013-2018)

10.4.2 Global Anti-inflammatory Price (2013-2018)

10.5 Anti-glaucoma Sales Growth and Price

10.5.1 Global Anti-glaucoma Sales Growth (2013-2018)

10.5.2 Global Anti-glaucoma Price (2013-2018)

11 Global Ophthalmic Drugs Market Segment by Application

11.1 Global Ophthalmic Drugs Sales Market Share by Application (2013-2018)

11.2 Hospital Sales Growth (2013-2018)

11.3 Clinic Sales Growth (2013-2018)

11.4 Pharmacy Sales Growth (2013-2018)

12 Ophthalmic Drugs Market Forecast (2018-2023)

12.1 Global Ophthalmic Drugs Sales, Revenue and Growth Rate (2018-2023)

12.2 Ophthalmic Drugs Market Forecast by Regions (2018-2023)

12.2.1 North America Ophthalmic Drugs Market Forecast (2018-2023)

12.2.2 Europe Ophthalmic Drugs Market Forecast (2018-2023)

12.2.3 Asia-Pacific Ophthalmic Drugs Market Forecast (2018-2023)

12.2.4 South America Ophthalmic Drugs Market Forecast (2018-2023)

12.2.5 Middle East and Africa Ophthalmic Drugs Market Forecast (2018-2023)

12.3 Ophthalmic Drugs Market Forecast by Type (2018-2023)

12.3.1 Global Ophthalmic Drugs Sales Forecast by Type (2018-2023)

12.3.2 Global Ophthalmic Drugs Market Share Forecast by Type (2018-2023)

12.4 Ophthalmic Drugs Market Forecast by Application (2018-2023)

12.4.1 Global Ophthalmic Drugs Sales Forecast by Application (2018-2023)

12.4.2 Global Ophthalmic Drugs Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source


List Of Table

List of Tables and Figures

Figure Ophthalmic Drugs Picture

Table Product Specifications of Ophthalmic Drugs

Figure Global Sales Market Share of Ophthalmic Drugs by Types in 2017

Table Ophthalmic Drugs Types for Major Manufacturers

Figure Anti-allergy Picture

Figure Anti-VEGF Agents Picture

Figure Anti-inflammatory Picture

Figure Anti-glaucoma Picture

Figure Ophthalmic Drugs Sales Market Share by Applications in 2017

Figure Hospital Picture

Figure Clinic Picture

Figure Pharmacy Picture

Figure United States Ophthalmic Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Canada Ophthalmic Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Mexico Ophthalmic Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Germany Ophthalmic Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure France Ophthalmic Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure UK Ophthalmic Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Russia Ophthalmic Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Italy Ophthalmic Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure China Ophthalmic Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Japan Ophthalmic Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Korea Ophthalmic Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure India Ophthalmic Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Southeast Asia Ophthalmic Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Brazil Ophthalmic Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Egypt Ophthalmic Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Saudi Arabia Ophthalmic Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure South Africa Ophthalmic Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Nigeria Ophthalmic Drugs Revenue (Value) and Growth Rate (2013-2023)

Table Santen Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table Santen Pharmaceutical Ophthalmic Drugs Type and Applications

Table Santen Pharmaceutical Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Valeant Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Valeant Pharmaceuticals Ophthalmic Drugs Type and Applications

Table Valeant Pharmaceuticals Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Shire Basic Information, Manufacturing Base and Competitors

Table Shire Ophthalmic Drugs Type and Applications

Table Shire Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Novartis Basic Information, Manufacturing Base and Competitors

Table Novartis Ophthalmic Drugs Type and Applications

Table Novartis Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Genentech Basic Information, Manufacturing Base and Competitors

Table Genentech Ophthalmic Drugs Type and Applications

Table Genentech Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Allergan Basic Information, Manufacturing Base and Competitors

Table Allergan Ophthalmic Drugs Type and Applications

Table Allergan Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors

Table Sun Pharmaceutical Industries Ophthalmic Drugs Type and Applications

Table Sun Pharmaceutical Industries Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Actavis Generics Basic Information, Manufacturing Base and Competitors

Table Actavis Generics Ophthalmic Drugs Type and Applications

Table Actavis Generics Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Regeneron Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Regeneron Pharmaceuticals Ophthalmic Drugs Type and Applications

Table Regeneron Pharmaceuticals Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Pfizer Basic Information, Manufacturing Base and Competitors

Table Pfizer Ophthalmic Drugs Type and Applications

Table Pfizer Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Johnson and Johnson Basic Information, Manufacturing Base and Competitors

Table Johnson and Johnson Ophthalmic Drugs Type and Applications

Table Johnson and Johnson Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Bausch and Lomb Basic Information, Manufacturing Base and Competitors

Table Bausch and Lomb Ophthalmic Drugs Type and Applications

Table Bausch and Lomb Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Global Ophthalmic Drugs Sales by Manufacturer (2016-2017)

Figure Global Ophthalmic Drugs Sales Market Share by Manufacturer in 2016

Figure Global Ophthalmic Drugs Sales Market Share by Manufacturer in 2017

Table Global Ophthalmic Drugs Revenue by Manufacturer (2016-2017)

Figure Global Ophthalmic Drugs Revenue Market Share by Manufacturer in 2016

Figure Global Ophthalmic Drugs Revenue Market Share by Manufacturer in 2017

Figure Top 3 Ophthalmic Drugs Manufacturer (Revenue) Market Share in 2017

Figure Top 6 Ophthalmic Drugs Manufacturer (Revenue) Market Share in 2017

Figure Global Ophthalmic Drugs Sales and Growth Rate (2013-2018)

Figure Global Ophthalmic Drugs Revenue and Growth Rate (2013-2018)

Table Global Ophthalmic Drugs Sales by Regions (2013-2018)

Table Global Ophthalmic Drugs Sales Market Share by Regions (2013-2018)

Table Global Ophthalmic Drugs Revenue by Regions (2013-2018)

Figure Global Ophthalmic Drugs Revenue Market Share by Regions in 2013

Figure Global Ophthalmic Drugs Revenue Market Share by Regions in 2017

Figure North America Ophthalmic Drugs Sales and Growth Rate (2013-2018)

Figure Europe Ophthalmic Drugs Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Ophthalmic Drugs Sales and Growth Rate (2013-2018)

Figure South America Ophthalmic Drugs Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Ophthalmic Drugs Sales and Growth Rate (2013-2018)

Figure North America Ophthalmic Drugs Revenue and Growth Rate (2013-2018)

Table North America Ophthalmic Drugs Sales by Countries (2013-2018)

Table North America Ophthalmic Drugs Sales Market Share by Countries (2013-2018)

Figure North America Ophthalmic Drugs Sales Market Share by Countries in 2013

Figure North America Ophthalmic Drugs Sales Market Share by Countries in 2017

Table North America Ophthalmic Drugs Revenue by Countries (2013-2018)

Table North America Ophthalmic Drugs Revenue Market Share by Countries (2013-2018)

Figure North America Ophthalmic Drugs Revenue Market Share by Countries in 2013

Figure North America Ophthalmic Drugs Revenue Market Share by Countries in 2017

Figure United States Ophthalmic Drugs Sales and Growth Rate (2013-2018)

Figure Canada Ophthalmic Drugs Sales and Growth Rate (2013-2018)

Figure Mexico Ophthalmic Drugs Sales and Growth Rate (2013-2018)

Figure Europe Ophthalmic Drugs Revenue and Growth Rate (2013-2018)

Table Europe Ophthalmic Drugs Sales by Countries (2013-2018)

Table Europe Ophthalmic Drugs Sales Market Share by Countries (2013-2018)

Table Europe Ophthalmic Drugs Revenue by Countries (2013-2018)

Figure Europe Ophthalmic Drugs Revenue Market Share by Countries in 2016

Figure Europe Ophthalmic Drugs Revenue Market Share by Countries in 2017

Figure Germany Ophthalmic Drugs Sales and Growth Rate (2013-2018)

Figure UK Ophthalmic Drugs Sales and Growth Rate (2013-2018)

Figure France Ophthalmic Drugs Sales and Growth Rate (2013-2018)

Figure Russia Ophthalmic Drugs Sales and Growth Rate (2013-2018)

Figure Italy Ophthalmic Drugs Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Ophthalmic Drugs Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Ophthalmic Drugs Sales by Countries (2013-2018)

Table Asia-Pacific Ophthalmic Drugs Sales Market Share by Countries (2013-2018)

Figure Asia-Pacific Ophthalmic Drugs Sales Market Share by Countries 2017

Table Asia-Pacific Ophthalmic Drugs Revenue by Countries (2013-2018)

Figure Asia-Pacific Ophthalmic Drugs Revenue Market Share by Countries 2017

Figure China Ophthalmic Drugs Sales and Growth Rate (2013-2018)

Figure Japan Ophthalmic Drugs Sales and Growth Rate (2013-2018)

Figure Korea Ophthalmic Drugs Sales and Growth Rate (2013-2018)

Figure India Ophthalmic Drugs Sales and Growth Rate (2013-2018)

Figure Southeast Asia Ophthalmic Drugs Sales and Growth Rate (2013-2018)

Figure South America Ophthalmic Drugs Revenue and Growth Rate (2013-2018)

Table South America Ophthalmic Drugs Sales by Countries (2013-2018)

Table South America Ophthalmic Drugs Sales Market Share by Countries (2013-2018)

Figure South America Ophthalmic Drugs Sales Market Share by Countries in 2017

Table South America Ophthalmic Drugs Revenue by Countries (2013-2018)

Table South America Ophthalmic Drugs Revenue Market Share by Countries (2013-2018)

Figure South America Ophthalmic Drugs Revenue Market Share by Countries in 2017

Figure Brazil Ophthalmic Drugs Sales and Growth Rate (2013-2018)

Figure Argentina Ophthalmic Drugs Sales and Growth Rate (2013-2018)

Figure Colombia Ophthalmic Drugs Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Ophthalmic Drugs Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Ophthalmic Drugs Sales by Countries (2013-2018)

Table Middle East and Africa Ophthalmic Drugs Sales Market Share by Countries (2013-2018)

Figure Middle East and Africa Ophthalmic Drugs Sales Market Share by Countries in 2017

Table Middle East and Africa Ophthalmic Drugs Revenue by Countries (2013-2018)

Table Middle East and Africa Ophthalmic Drugs Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Ophthalmic Drugs Revenue Market Share by Countries in 2013

Figure Middle East and Africa Ophthalmic Drugs Revenue Market Share by Countries in 2017

Figure Saudi Arabia Ophthalmic Drugs Sales and Growth Rate (2013-2018)

Figure UAE Ophthalmic Drugs Sales and Growth Rate (2013-2018)

Figure Egypt Ophthalmic Drugs Sales and Growth Rate (2013-2018)

Figure Nigeria Ophthalmic Drugs Sales and Growth Rate (2013-2018)

Figure South Africa Ophthalmic Drugs Sales and Growth Rate (2013-2018)

Table Global Ophthalmic Drugs Sales by Type (2013-2018)

Table Global Ophthalmic Drugs Sales Share by Type (2013-2018)

Table Global Ophthalmic Drugs Revenue by Type (2013-2018)

Table Global Ophthalmic Drugs Revenue Share by Type (2013-2018)

Figure Global Anti-allergy Sales Growth (2013-2018)

Figure Global Anti-allergy Price (2013-2018)

Figure Global Anti-VEGF Agents Sales Growth (2013-2018)

Figure Global Anti-VEGF Agents Price (2013-2018)

Figure Global Anti-inflammatory Sales Growth (2013-2018)

Figure Global Anti-inflammatory Price (2013-2018)

Figure Global Anti-glaucoma Sales Growth (2013-2018)

Figure Global Anti-glaucoma Price (2013-2018)

Table Global Ophthalmic Drugs Sales by Application (2013-2018)

Table Global Ophthalmic Drugs Sales Share by Application (2013-2018)

Figure Global Clinic Sales Growth (2013-2018)

Figure Global Pharmacy Sales Growth (2013-2018)

Figure Global Ophthalmic Drugs Sales, Revenue and Growth Rate (2018-2023)

Table Global Ophthalmic Drugs Sales Forecast by Regions (2018-2023)

Table Global Ophthalmic Drugs Market Share Forecast by Regions (2018-2023)

Figure North America Sales Ophthalmic Drugs Market Forecast (2018-2023)

Figure Europe Sales Ophthalmic Drugs Market Forecast (2018-2023)

Figure Asia-Pacific Sales Ophthalmic Drugs Market Forecast (2018-2023)

Figure South America Sales Ophthalmic Drugs Market Forecast (2018-2023)

Figure Middle East and Africa Sales Ophthalmic Drugs Market Forecast (2018-2023)

Table Global Ophthalmic Drugs Sales Forecast by Type (2018-2023)

Table Global Ophthalmic Drugs Market Share Forecast by Type (2018-2023)

Table Global Ophthalmic Drugs Sales Forecast by Application (2018-2023)

Table Global Ophthalmic Drugs Market Share Forecast by Application (2018-2023)

Table Distributors/Traders/ Dealers List

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Companies

Santen Pharmaceutical

Valeant Pharmaceuticals

Shire

Novartis

Genentech

Allergan

Sun Pharmaceutical Industries

Actavis Generics

Regeneron Pharmaceuticals

Pfizer

Johnson and Johnson

Bausch and Lomb